CoChat

Critical role of NF-κB in pancreatic cancer

Open access
Prabhu, Lakshmi, Mundade, Rasika, Korc, Murray, Loehrer, Patrick J., Lu, Tao · 2014 · Oncotarget
Cited by 148

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Lakshmi Prabhu 1 , Rasika Mundade 1 , Murray Korc 2, 3 , Patrick J. Loehrer 4 , Tao Lu 1, 3, 5 1 Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA 2 Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA 3 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA 4 Division of Hematology and Oncology, Indiana Cancer Pavilion, Indianapolis, IN, USA 5 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA Correspondence to: Tao Lu, e-mail: lut@iupui.edu Keywords: NF-κB, pancreatic cancer Received: August 26, 2014 Accepted: October 23, 2014 Published: December 19, 2014 ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, and in spite of intense efforts there are limited therapeutic options for patients with PDAC. PDACs harbor a high frequency of Kras mutations and other driver mutations that lead to altered signaling pathways and contribute to therapeutic resistance. Importantly, constitutive activation of nuclear factor κB (NF-κB) is frequently observed in PDAC. An increasing body of evidence suggests that both classical and non-classical NF-κB pathways play a crucial role in PDAC development and progression. In this review, we update the most recent advances regarding different aspects of NF-κB involvement in PDAC development and progression, emphasizing its potential as a therapeutic target and the need to discover pathway-specific cytosolic NF-κB regulators which could be used to design novel therapeutic strategies for PDAC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2624

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 148

Metadata

Authors
Prabhu, L., Mundade, R., Korc, M., Loehrer, P. J., & Lu, T.
Venue
Oncotarget
Published
2014-11-30
Volume
5
Issue
22
Pages
10969-10975
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2143192323
Cited by
148
References
7
FWCI
3.40
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.